BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.97B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$613M |
| 3 |
SPDR S&P Biotech ETF
XBI
|
+$189M |
| 4 |
Canadian Pacific Kansas City
CP
|
+$138M |
| 5 |
Merck
MRK
|
+$134M |
Top Sells
| 1 |
Apple
AAPL
|
+$930M |
| 2 |
Bank of America
BAC
|
+$284M |
| 3 |
VanEck Gold Miners ETF
GDX
|
+$190M |
| 4 |
Canadian National Railway
CNI
|
+$184M |
| 5 |
Meta Platforms (Facebook)
META
|
+$143M |
Sector Composition
| 1 | Technology | 10.29% |
| 2 | Financials | 8.4% |
| 3 | Consumer Discretionary | 5.96% |
| 4 | Industrials | 5.95% |
| 5 | Healthcare | 5.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1951
The Ensign Group
ENSG
$9.69B
| $118K | ﹤0.01% |
4,954
+3,802
| +330% | +$90.8K |
|
|
NMBL
1952
DELISTED
Nimble Storage, Inc.
NMBL
| $118K | ﹤0.01% |
4,215
+4,001
| +1,870% | +$112K |
|
1953
PotlatchDeltic
PCH
$3.2B
| $118K | ﹤0.01% |
3,339
+1,643
| +97% | +$58K |
|
|
BLUE
1954
DELISTED
bluebird bio
BLUE
| $118K | ﹤0.01% |
54
+18
| +50% | +$39.2K |
|
|
HW
1955
DELISTED
Headwaters Inc
HW
| $117K | ﹤0.01% |
6,419
+4,189
| +188% | +$76.3K |
|
1956
MannKind Corp
MNKD
$1.71B
| $117K | ﹤0.01% |
4,106
+1,808
| +79% | +$51.4K |
|
1957
Larimar Therapeutics
LRMR
$336M
| $117K | ﹤0.01% |
281
+185
| +193% | +$76.9K |
|
|
NTUS
1958
DELISTED
Natus Medical Inc
NTUS
| $117K | ﹤0.01% |
2,743
+1,986
| +262% | +$84.5K |
|
|
OREX
1959
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $116K | ﹤0.01% |
2,351
+62
| +3% | +$3.07K |
|
1960
Evertec
EVTC
$2.14B
| $116K | ﹤0.01% |
5,473
+3,914
| +251% | +$83.1K |
|
1961
Simmons First National
SFNC
$2.96B
| $116K | ﹤0.01% |
4,968
+4,206
| +552% | +$98.2K |
|
|
MNTA
1962
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $116K | ﹤0.01% |
5,082
+3,945
| +347% | +$90K |
|
1963
Wabtec
WAB
$32.3B
| $116K | ﹤0.01% |
1,228
-1,785
| -59% | -$168K |
|
|
PLKI
1964
DELISTED
Popeyes Louisiana Kitchen, Inc.
PLKI
| $116K | ﹤0.01% |
1,926
+1,369
| +246% | +$82.1K |
|
1965
WesBanco
WSBC
$3.03B
| $115K | ﹤0.01% |
3,391
+2,622
| +341% | +$89.2K |
|
|
ARIA
1966
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $115K | ﹤0.01% |
13,928
+10,017
| +256% | +$82.8K |
|
|
HMSY
1967
DELISTED
HMS Holdings Corp.
HMSY
| $115K | ﹤0.01% |
6,707
+5,179
| +339% | +$88.9K |
|
1968
Morningstar
MORN
$10.8B
| $115K | ﹤0.01% |
1,443
+173
| +14% | +$13.8K |
|
1969
Alaunos Therapeutics
TCRT
$5.1M
| $115K | ﹤0.01% |
64
+50
| +357% | +$89.5K |
|
|
CBM
1970
DELISTED
Cambrex Corporation
CBM
| $114K | ﹤0.01% |
2,605
+1,874
| +256% | +$82.3K |
|
|
BEL
1971
DELISTED
Belmond Ltd.
BEL
| $114K | ﹤0.01% |
9,154
+5,764
| +170% | +$72K |
|
1972
Diodes
DIOD
$2.44B
| $114K | ﹤0.01% |
4,734
+3,615
| +323% | +$87.2K |
|
1973
Quaker Houghton
KWR
$2.46B
| $114K | ﹤0.01% |
1,283
+968
| +307% | +$86K |
|
1974
Eagle Bancorp
EGBN
$615M
| $114K | ﹤0.01% |
2,591
+1,969
| +317% | +$86.6K |
|
|
TSRO
1975
DELISTED
TESARO, Inc.
TSRO
| $114K | ﹤0.01% |
1,936
+1,482
| +326% | +$87.1K |
|